<p>In traditional toxicology trials, pharmacokinetics (PK) is investigated in the satellite group of animals, and the pharmacodynamics (PD) is investigated in the study group of animals. The new blood sampling method of microsampling opens up the opportunity to investigate both PK and PD in the same animals. To avoid excessive burden on the animals from the required blood sampling, sparse sampling schemes are typically used. Motivated by this application, this article introduces a procedure to choose an optimal sparse sampling scheme and sampling time points using non-compartmental methods but which can be applied to further settings beyond this. We discuss how robust designs can be obtained and we apply and evaluate the approach to a range...
Minimum size sampling schedules for estimating glucose kinetic parameters from an impulsive (bolus) ...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
In traditional toxicology trials, pharmacokinetics (PK) is investigated in the satellite group of an...
The goal of this manuscript is to introduce a framework for consideration of designs for population ...
In clinical pharmacokinetic (PK) studies multiple blood samples are taken for each enrolled patient,...
Pharmacokinetic studies aim to study how a compound is absorbed, distributed, metabolised, and excre...
Optimal sampling design with nonparametric population modeling offers the opportunity to determine p...
Objectives: In many pharmaceutical studies multiple blood samples are taken for each enrolled patien...
International audienceOur paper proposes a methodological strategy to select optimal sampling design...
In pharmacokinetic (PK) studies, blood samples are taken over time on subjects after the administrat...
Pharmacokinetic (PK) studies aim to understand the kinetics of absorption, distribution, metabolism ...
International audienceBACKGROUND: Since 2007, it is mandatory for the pharmaceutical companies to su...
Based on toxicokinetic studies of a destructive sampling design, this work was aimed at selecting th...
The parameter estimation problem for dynamic system models designed for diagnostic use is often a di...
Minimum size sampling schedules for estimating glucose kinetic parameters from an impulsive (bolus) ...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
In traditional toxicology trials, pharmacokinetics (PK) is investigated in the satellite group of an...
The goal of this manuscript is to introduce a framework for consideration of designs for population ...
In clinical pharmacokinetic (PK) studies multiple blood samples are taken for each enrolled patient,...
Pharmacokinetic studies aim to study how a compound is absorbed, distributed, metabolised, and excre...
Optimal sampling design with nonparametric population modeling offers the opportunity to determine p...
Objectives: In many pharmaceutical studies multiple blood samples are taken for each enrolled patien...
International audienceOur paper proposes a methodological strategy to select optimal sampling design...
In pharmacokinetic (PK) studies, blood samples are taken over time on subjects after the administrat...
Pharmacokinetic (PK) studies aim to understand the kinetics of absorption, distribution, metabolism ...
International audienceBACKGROUND: Since 2007, it is mandatory for the pharmaceutical companies to su...
Based on toxicokinetic studies of a destructive sampling design, this work was aimed at selecting th...
The parameter estimation problem for dynamic system models designed for diagnostic use is often a di...
Minimum size sampling schedules for estimating glucose kinetic parameters from an impulsive (bolus) ...
Simultaneous modelling of dense and sparse pharmacokinetic data is possible with a population approa...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...